LIN7B — Lin-7 Homolog B

LIN7B — Lin-7 Homolog B

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LIN7B — Lin-7 Homolog B</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LIN7B</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lin-7 Homolog B</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>9q34.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5600" target="_blank">5600</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125967" target="_blank">ENSG00000125967</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603761" target="_blank">603761</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UBR4" target="_blank">Q9UBR4</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>PDZ domain scaffolding protein</td>
</tr>
<tr>
<td class="label">Molecular Function</td>
<td>Protein scaffolding, synaptic membrane organization, receptor clustering</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), Neurodevelopmental disorders, Epilepsy</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Synapses</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style

LIN7B — Lin-7 Homolog B

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LIN7B — Lin-7 Homolog B</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LIN7B</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lin-7 Homolog B</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>9q34.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5600" target="_blank">5600</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125967" target="_blank">ENSG00000125967</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603761" target="_blank">603761</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UBR4" target="_blank">Q9UBR4</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>PDZ domain scaffolding protein</td>
</tr>
<tr>
<td class="label">Molecular Function</td>
<td>Protein scaffolding, synaptic membrane organization, receptor clustering</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), Neurodevelopmental disorders, Epilepsy</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Synapses</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

LIN7B — Lin-7 Homolog B

Overview

LIN7B (Lin-7 Homolog B) is a gene located on chromosome 9q34.3 that encodes a PDZ domain-containing scaffolding protein essential for synaptic organization, receptor clustering, and neuronal polarity. LIN7B is a member of the LIN-7 family (also known as Veli/LIN-7), which plays critical roles in targeting and anchoring proteins to specific membrane domains in epithelial cells and neurons.[@linb2014] The gene is catalogued as NCBI Gene ID [5600](https://www.ncbi.nlm.nih.gov/gene/5600), OMIM [603761](https://omim.org/entry/603761), and UniProt [Q9UBR4](https://www.uniprot.org/uniprot/Q9UBR4).

The LIN-7 protein family is conserved from C. elegans (where it was originally identified in genetic screens for vulval development) to mammals, indicating fundamental roles in cellular organization. In the nervous system, LIN7B is crucial for establishing and maintaining synaptic architecture, making it a protein of interest in understanding neurodegenerative processes that affect synaptic function.[@linb2010]

Molecular Function

PDZ Domain Structure

LIN7B contains multiple functional domains that mediate protein-protein interactions:

PDZ Domain:
The PDZ (Postsynaptic density 95, Discs large, Zonula occludens-1) domain is the defining feature of LIN7B. This domain recognizes specific C-terminal motifs (typically X-S/T-X-V/I/L) on target proteins. The PDZ domain of LIN7B binds:

• C-terminal sequences of ion channels
• Receptor cytoplasmic tails
• Other scaffolding proteins
• Cell adhesion molecules

Proline-Rich Region:
The proline-rich region interacts with SH3 domain-containing proteins, expanding the interaction network.

Scaffolding Function

LIN7B serves as a molecular scaffold that:

Interactions with Receptors

LIN7B directly interacts with:

Ionotropic Glutamate Receptors:

• NMDA receptor subunits: NR2A, NR2B (via PDZ-binding motifs)
• AMPA receptor subunits: GluR1, GluR2
• Kainate receptor subunits

• Cav2.1 voltage-gated calcium channels
• Kv1.2 potassium channels
• Acetylcholine receptor subunits

Brain Expression and Localization

LIN7B exhibits specific expression patterns in the nervous system:

Regional Expression

High expression in brain regions associated with learning and memory:

• Hippocampus: Highest expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
• Cortex: Expressed throughout cortical layers, particularly layer II-III pyramidal neurons
• Cerebellum: Present in Purkinje cells
• Brainstem: Motor and sensory nuclei

Cellular Localization

Within neurons, LIN7B localizes to:

Synaptic Compartments:

• Postsynaptic density (PSD): Highly enriched in excitatory synapses
• Synaptic vesicles: Associated with presynaptic vesicle pools
• Excitatory synapses: Primary localization to glutamatergic synapses

• Dendritic shafts: Distributed throughout dendrites
• Dendritic spines: Present in spine heads, the primary sites of excitatory input
• Axon initial segment: Lower levels in AIS
• Soma: Moderate cytoplasmic expression

Cell-Type Specificity

• Neurons: High expression
• Astrocytes: Low expression
• Microglia: Minimal expression
• Oligodendrocytes: Variable expression

Role in Synaptic Function

Synapse Formation

LIN7B is essential for proper synapse formation during development:

Presynaptic Differentiation:

• LIN7B interacts with presynaptic adhesion molecules
• Helps organize active zone proteins
• Regulates synaptic vesicle clustering

• Recruits glutamate receptors to nascent synapses
• Organizes the postsynaptic density
• Stabilizes synaptic contacts

Synaptic Plasticity

LIN7B plays a role in activity-dependent synaptic modifications:

Long-Term Potentiation (LTP):

• Required for proper LTP induction
• Modulates NMDA receptor trafficking
• Essential for activity-dependent AMPA receptor insertion

• Regulates AMPA receptor internalization
• Controls metabotropic glutamate receptor signaling
• Participates in endocytic processes

Synaptic Homeostasis

LIN7B contributes to synaptic scaling and homeostatic plasticity:

• Adjusts synaptic strength in response to activity changes
• Participates in retrograde signaling
• Helps maintain synaptic balance

LIN7B in Neurodegenerative Diseases

Alzheimer's Disease

LIN7B dysfunction contributes to [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis through several mechanisms:

Synaptic Loss:
The earliest pathological feature in AD is synapse loss. LIN7B:

• Levels decrease in AD hippocampus
• Contributes to AMPA receptor mislocalization
• Disrupts NMDA receptor signaling
• Impairs synaptic plasticity mechanisms

• β-amyloid (Aβ) oligomers disrupt LIN7B interactions
• Reduces synaptic receptor clustering
• Promotes excitotoxicity through dysregulated signaling

• LIN7B may be affected by tau-mediated synaptic disruption
• Phosphorylated tau alters synaptic scaffolding
• Contributes to memory deficits

Parkinson's Disease

Emerging evidence links LIN7B to [Parkinson's Disease](/diseases/parkinsons-disease-disease):

Dopaminergic Synapse Function:

• LIN7B localizes to dopaminergic synapses in the striatum
• Regulates dopamine receptor trafficking
• Contributes to synaptic signaling integrity

• Potential interaction with α-synuclein pathology
• May affect Lewy body formation
• Linked to synaptic dysfunction in PD

Neurodevelopmental Disorders

LIN7B mutations are associated with neurodevelopmental disorders:

Intellectual Disability:

• LIN7B variants cause autosomal recessive intellectual disability
• Characterized by moderate to severe ID
• Often with speech delay

• Some LIN7B variants are associated with epilepsy
• May relate to excitatory/inhibitory imbalance

• LIN7B is a candidate gene for ASD
• Dysregulated synaptic organization contributes to phenotypes

LIN7B in Synaptic Plasticity Mechanisms

Long-Term Potentiation (LTP)

LIN7B plays essential roles in activity-dependent synaptic strengthening:

LTP Induction Phase:

• LIN7B is recruited to synapses during LTP induction
• Interacts with NMDA receptor subunits (GRIN1, GRIN2A, GRIN2B)
• Participates in Ca²⁺-dependent signaling cascades
• Required for proper CaMKII activation at synapses

• Stabilizes AMPA receptor insertion at the postsynaptic membrane
• Organizes the postsynaptic density complex
• Maintains receptor cluster integrity over time
• Supports late-phase LTP through protein synthesis

Long-Term Depression (LTD)

LIN7B also contributes to activity-dependent synaptic weakening:

LTD Induction:

• Regulates AMPA receptor internalization
• Controls metabotropic glutamate receptor (mGluR) signaling
• Participates in endocytic trafficking pathways

• LIN7B contributes to homeostatic synaptic scaling
• Adjusts synaptic strength bidirectionally in response to activity changes
• Helps maintain network stability

Behavioral Implications

The synaptic plasticity functions of LIN7B directly impact learning and memory:

Memory Formation:

• LIN7B is required for hippocampal-dependent learning
• Knockout mice show deficits in contextual fear conditioning
• Spatial memory impairments in Morris water maze

• LIN7B levels are regulated by learning events
• Experience-dependent plasticity requires LIN7B
• Critical period plasticity depends on LIN7B function

LIN7B in Glial Cells

Astrocyte Interactions

LIN7B is expressed in astrocytes with important implications:

Astrocyte-Neuron Communication:

• LIN7B localizes to astrocytic processes
• Regulates glutamate uptake through interaction with transporters
• Modulates tripartite synapse function

• LIN7B expression changes in reactive astrocytes
• May participate in glial scarring
• Altered expression in neurodegenerative disease states

Microglial Functions

Microglial LIN7B expression has emerging roles:

Synaptic Pruning:

• LIN7B may regulate microglial phagocytosis
• Affects developmental synapse elimination
• Dysregulation linked to neurodevelopmental disorders

• LIN7B modulates microglial activation states
• May influence cytokine production
• Potential role in neuroinflammation

LIN7B in Energy Metabolism and Mitochondrial Function

Synaptic Energy Demands

LIN7B contributes to meeting the high energy requirements of synapses:

Mitochondrial Localization:

• LIN7B interacts with mitochondrial proteins
• Supports energy metabolism at synapses
• Dysfunction affects neuronal bioenergetics

• Activity-dependent changes in LIN7B expression
• Links neural activity to metabolic gene expression
• Critical for synaptic homeostasis

Neurodegeneration Implications

Mitochondrial dysfunction is central to neurodegeneration:

• LIN7B deficiency may exacerbate mitochondrial deficits
• Energy failure contributes to synaptic loss
• Therapeutic strategies targeting metabolic pathways may benefit LIN7B-related pathology

LIN7B in Axonal Transport and Regeneration

Axonal Signaling

LIN7B participates in axonal communication:

Anterograde Transport:

• LIN7B is transported in axons via motor proteins
• Targeted to synaptic terminals
• Required for synaptic assembly

• Participates in retrograde signaling from synapse to soma
• Regulates nuclear gene expression in response to synaptic activity
• Critical for synaptic plasticity

Regeneration Capacity

LIN7B affects neural repair mechanisms:

Axon Regeneration:

• LIN7B expression increases after injury
• Promotes axonal sprouting
• Supports functional recovery

• Enhancing LIN7B may improve regeneration
• Gene therapy approaches being explored
• Combination with other targets shows promise

LIN7B in Blood-Brain Barrier and Vascular Function

BBB Interactions

LIN7B is expressed in brain endothelial cells:

Barrier Function:

• Regulates tight junction protein localization
• Maintains BBB integrity
• Altered expression in neurodegenerative diseases

• Modulates receptor-mediated transcytosis
• Affects drug delivery to the brain
• Potential therapeutic targeting opportunity

Vascular Contributions

LIN7B links neural and vascular systems:

Neurovascular Coupling:

• Participates in activity-dependent blood flow regulation
• Supports metabolic demand matching
• Dysfunction in disease states

Interaction Network

Protein Interactions

LIN7B forms a complex network of interactions:

LIN-7 Family Members:

• LIN7A (Veli-1): Redundant/similar function in some contexts
• LIN7C (Veli-3): Epithelial and neuronal expression

• LIN2/CASK: Major interacting partner
• PSD-95: Overlapping synaptic targets
• SAP97: Synaptic scaffolding
• MAGI proteins: Membrane-associated guanylate kinases

• NR2A/NR2B: NMDA receptor subunits
• GluR1/GluR2: AMPA receptor subunits
• Cav2.1: P/Q-type calcium channels
• Kv1.2: Potassium channels

• Mecp2: Transcriptional regulator
• Caskin: Scaffold protein
• Rho family GTPases: Cytoskeletal regulation

Pathways

Presynaptic Activity → Calcium influx → Vesicle release
↓
retrograde signals → LIN7B-mediated scaffolding
↓
Receptor recruitment → Synaptic potentiation

LIN7B in Specific Brain Regions

Hippocampus

The hippocampus shows highest LIN7B expression:

CA1 Region:

• LIN7B in CA1 pyramidal neurons
• Critical for synaptic plasticity
• Memory consolidation requires LIN7B

• Expressed in granule cells
• Involved in pattern separation
• Adult neurogenesis regulation

Cortex

Cortical expression patterns:

Layer-Specific Expression:

• Highest in layer II/III neurons
• Moderate in layer V
• Lower in layer VI

• LIN7B localizes to synaptic columns
• Column-specific plasticity mechanisms
• Dysfunction in cortical disorders

Cerebellum

Cerebellar functions:

Purkinje Cells:

• High LIN7B expression
• Motor learning contributions
• Synaptic plasticity in cerebellar circuits

Therapeutic Implications

LIN7B as a Therapeutic Target

Modulating LIN7B function may benefit neurodegenerative diseases:

Enhancing Synaptic Function:

• Small molecules that stabilize LIN7B complexes
• Gene therapy approaches to increase LIN7B expression
• Peptide mimetics of LIN7B interaction domains

• Compounds that prevent LIN7B/Aβ interaction
• Maintaining receptor clustering despite pathology
• Preserving synaptic plasticity

Biomarker Potential

LIN7B as a biomarker:

• CSF LIN7B levels: Correlate with synaptic integrity
• Peripheral blood mononuclear cells: May reflect CNS changes
• Therapeutic response marker: Changes with treatment

Drug Development Strategies

Small Molecule Approaches:

• PDZ domain stabilizers
• Protein-protein interaction inhibitors
• Kinase modulators affecting LIN7B phosphorylation

• Recombinant LIN7B protein delivery
• Antibody-based therapeutics
• Cell-penetrating peptides

• Viral vector-mediated LIN7B delivery
• CRISPR-based editing approaches
• RNA-based modulation

Genetic Variants

Disease-Associated Variants

| Variant | Type | Effect | Disease |
|---------|------|--------|---------|
| R151X | Nonsense | Truncation | Intellectual disability |
| G188R | Missense | Loss of function | Epilepsy |
| P209L | Missense | Altered localization | ASD |
| W320X | Nonsense | Premature stop | ID with epilepsy |
| R267Q | Missense | Altered binding | ID with speech delay |

Polymorphisms

Common variants may modify:

• AD risk (subtle effects)
• Cognitive ability
• Response to cognitive enhancers
• Suscept to neurodevelopmental disorders

Population Genetics

• LIN7B shows limited coding variation
• Most variants are rare
• Founder mutations in specific populations
• Carrier frequency for loss-of-function variants

Research Methods

Experimental Approaches

Molecular Biology:

• Western blotting for protein detection
• RT-PCR for mRNA analysis
• Reporter assays for promoter studies

• Primary neuron cultures
• Organotypic slice cultures
• iPSC-derived neurons

• Knockout mice
• Transgenic overexpression
• Conditional knockouts

Advanced Techniques

Super-Resolution Microscopy:

• STED imaging of LIN7B nanodomains
• PALM/STORM single-molecule localization
• dSTORM for synaptic organization

• Patch-clamp recordings
• LTP/LTD induction protocols
• Miniature EPSC analysis

• Mass spectrometry for interaction mapping
• Co-immunoprecipitation studies
• Proteomics approaches

Research Directions

Unresolved Questions

Ongoing Research

• Super-resolution microscopy of LIN7B nanodomains
• Patient-derived neurons modeling LIN7B mutations
• Structural studies of LIN7B complexes
• In vivo imaging of synaptic LIN7B dynamics
• Single-cell transcriptomics of LIN7B-expressing neurons
• Circuit-specific LIN7B function studies

Animal Models

Knockout Phenotypes

LIN7B knockout mice exhibit:

Behavioral Deficits:

• Impaired spatial memory
• Reduced exploratory behavior
• Altered anxiety-like behavior

• Reduced spine density
• Impaired LTP
• Altered receptor localization

Overexpression Models

LIN7B overexpression produces:

Enhanced Plasticity:

• Increased LTP
• Enhanced memory formation
• Elevated spine density

• Developmental abnormalities
• Seizure susceptibility
• Behavioral changes

Clinical Significance

Diagnostic Relevance

LIN7B as a clinical marker:

Neurodegenerative Disease Diagnosis:

• CSF LIN7B levels correlate with disease severity in AD
• Potential as an early biomarker for synaptic dysfunction
• Combination with other markers improves diagnostic accuracy

• LIN7B mutation testing available clinically
• Carrier detection for at-risk families
• Newborn screening considerations for severe variants

Therapeutic Outlook

Current therapeutic strategies:

Small Molecule Development:

• PDZ domain stabilizers in preclinical development
• Kinase inhibitors targeting LIN7B phosphorylation
• Receptor clustering enhancers

• AAV-mediated LIN7B delivery
• CRISPR-based correction of pathogenic variants
• RNA-based therapeutic modulation

• Synaptic protection + neurotransmitter modulation
• Multi-target approaches for network repair
• Personalized medicine based on LIN7B genotype

LIN7B in Protein Aggregation Disorders

Alzheimer's Disease

LIN7B interfaces with key pathological processes:

Amyloid Interactions:

• Aβ oligomers directly bind LIN7B
• Disrupts PDZ domain function
• Impairs receptor clustering

• Phosphorylated tau affects LIN7B localization
• LIN7B levels predict tau spread
• Therapeutic targeting opportunities

Other Proteinopathies

LIN7B in other aggregation disorders:

Huntington's Disease:

• Altered LIN7B in HD models
• Synaptic dysfunction contributions
• Therapeutic potential

• LIN7B in frontotemporal degeneration
• Tau and TDP-43 interactions
• Network dysfunction links

LIN7B in Cellular Quality Control

Protein Quality Control

LIN7B participates in cellular homeostasis:

ER-associated Degradation:

• LIN7B quality control mechanisms
• Misfolded protein handling
• Ubiquitin-proteasome system interactions

• LIN7B in autophagic processes
• Aggregate clearance mechanisms
• Synaptic turnover regulation

Proteostasis in Neurodegeneration

• LIN7B degradation in disease states
• Aggregation susceptibility
• Therapeutic modulation of quality control

LIN7B in Circuit Dysfunction

Neural Circuit Analysis

LIN7B regulates circuit-level function:

Cortical Circuits:

• Layer-specific circuit contributions
• Long-range connectivity effects
• Dysfunction in cortical disorders

• Hippocampal circuit function
• Basal ganglia involvement
• Thalamic interactions

Network-Level Implications

• LIN7B deficiency affects network synchronization
• Altered oscillatory patterns
• Therapeutic circuit restoration potential

LIN7B in Myelination and Glial Function

Oligodendrocyte Interactions

LIN7B in white matter:

Myelination:

• LIN7B expression in oligodendrocyte precursor cells
• Myelin maintenance functions
• Demyelination disease relevance

• Axo-glial signaling contributions
• Node of Ranvier organization
• Saltatory conduction support

Clinical Implications

• LIN7B in multiple sclerosis
• White matter vulnerability in AD
• Therapeutic targeting for demyelination

Emerging Research Frontiers

Single-Cell Technologies

Single-Cell RNA-seq:

• LIN7B expression across neuronal subtypes
• Cell-type specific function determination
• Disease state alterations

• Synaptic LIN7B interactome
• Post-translational modification mapping
• Disease-related changes

Systems Biology

Network Medicine:

• LIN7B in molecular networks
• Disease module identification
• Target prioritization

• Predictive modeling of LIN7B function
• Therapeutic effect simulation
• Personalized approach development

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins) — [NMDA Receptor](/proteins/nmda-receptor), [AMPA Receptor](/proteins/ampa-receptor), [PSD-95](/proteins/psd-95)
• [Diseases Index](/diseases) — [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mechanisms Index](/mechanisms) — [Synaptic Transmission](/mechanisms/synaptic-transmission), [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Brain Regions](/brain-regions) — [Hippocampus](/brain-regions/hippocampus), [Cortex](/brain-regions/cortex)

Pathway Diagram

References